- Home
- CLDI vs SNTG Comparison
CLDI vs SNTG Comparison
Compare CLDI & SNTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CLDI | SNTG |
|---|---|---|
| Founded | 2014 | 2009 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6M | 5.4M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | CLDI | SNTG |
|---|---|---|
| Price | $0.30 | $1.98 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 265.3K | 23.3K |
| Earning Date | 03-16-2026 | 12-19-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.22 | $1.43 |
| 52 Week High | $7.32 | $12.70 |
Technical Indicators
Market Signals| Indicator | CLDI | SNTG |
|---|---|---|
| Relative Strength Index (RSI) | 18.85 | 51.03 |
| Support Level | $0.22 | $1.97 |
| Resistance Level | $0.90 | $2.11 |
| Average True Range (ATR) | 0.04 | 0.07 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 0.04 | 52.00 |
Price Performance
Historical ComparisonAbout CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.
About SNTG Sentage Holdings Inc.
Sentage Holdings Inc is a financial service provider that offers a comprehensive range of financial services across consumer loan repayment and collection management, loan recommendation, and prepaid payment network services in China.